Neurocysticercosis: relationship between Taenia antigen levels in CSF and MRI. (Q48258953)

10 February 2018

title

Neurocysticercosis: relationship between Taenia antigen levels in CSF and MRI. (English)

1 reference

10 February 2018

1 reference

Ronaldo Abraham

1

1 reference

10 February 2018

José Antonio Livramento

2

1 reference

10 February 2018

Cláudia da Costa Leite

3

1 reference

10 February 2018

Alessandra Xavier Pardini

4

1 reference

10 February 2018

Adelaide José Vaz

5

1 reference

10 February 2018

Luís dos Ramos Machado

6

1 reference

10 February 2018

publication date

1 February 2010

1 reference

10 February 2018

Arquivos de Neuro-Psiquiatria

published in

1 reference

10 February 2018

volume

68

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

7-11

1 reference

10 February 2018

Neurocysticercosis: an update.

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Neurocysticercosis: updated concepts about an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Magnitude of the disease burden from neurocysticercosis in a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Neurocysticercosis in the United States: review of an important emerging infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Neurocysticercosis in Oregon, 1995-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Neurocysticercosis. An emergent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Neurocysticercosis: a major cause of neurological disease worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Cellular immune response of patients with neurocysticercosis (inflammatory and non-inflammatory phases).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Proposed diagnostic criteria for neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Diagnosis, treatment and control of Taenia solium cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Cysticercus antigens in cerebrospinal fluid samples from patients with neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Evaluation of lower molecular mass (20-24 kDa) Taenia solium cysticercus antigen fraction by ELISA and dot blot for the serodiagnosis of neurocysticercosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

Neurocysticercosis and Population Movements: Analysis of 23 Imported Cases in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2010000100003

10.1590/S0004-282X2010000100003

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

20339644

1 reference

10 February 2018